Article
Islet-Derived eATP Fuels Autoreactive CD8+ T Cells and Facilitates the Onset of Type 1 Diabetes.
Diabetes - 1 Oct 2018
Tezza Sara, Ben Nasr Moufida, D'Addio Francesca, Vergani Andrea, Usuelli Vera, Falzoni Simonetta, Bassi Roberto, Dellepiane Sergio, Fotino Carmen, Rossi Chiara, Maestroni Anna, Solini Anna, Corradi Domenico, Giani Elisa, Mameli Chiara, Bertuzzi Federico, Pezzolesi Marcus G, Wasserfall Clive H, Atkinson Mark A, Füchtbauer Ernst-Martin, Ricordi Camillo, Folli Franco, Di Virgilio Francesco, Pileggi Antonello, Dhe-Paganon Sirano, Zuccotti Gian Vincenzo, Fiorina Paolo
Abstract excerpt
Extracellular ATP (eATP) activates T cells by engaging the P2X7R receptor. We identified two loss-of-function P2X7R mutations that are protective against type 1 diabetes (T1D) and thus hypothesized that eATP/P2X7R signaling may represent an early step in T1D onset. Specifically, we observed that in patients with newly diagnosed T1D, P2X7R is upregulated on CD8+ effector T cells in comparison with healthy control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
